Chapter 28. Novel Inhibitors of the Proteasome and Their Therapeutic Use in Inflammation
- 1 January 1996
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Kinetic Characterization of the Chymotryptic Activity of the 20S ProteasomeBiochemistry, 1996
- New insights into proteasome function: from archaebacteria to drug developmentChemistry & Biology, 1995
- A role for phosphorylation in the proteolytic processing of the human NF-KB1 precursorGene, 1995
- Existence of a molecular ruler in proteasomes suggested by analysis of degradation productsFEBS Letters, 1994
- Immunosuppresive boronic acid dipeptides: correlation between conformation and activityJournal of the American Chemical Society, 1993
- Purification and Characterization of a Z-Leu-Leu-Leu-MCA Degrading Protease Expected to Regulate Neurite Formation: A Novel Catalytic Activity in ProteasomeBiochemical and Biophysical Research Communications, 1993
- Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acidsBiochemistry, 1993
- A 3,4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complexBiochemistry, 1992
- 3,4‐Dichloroisocoumarin, a serine protease inhibitor, inactivates glycogen phosphorylase bFEBS Letters, 1990
- Electron microscopy and image analysis of the multicatalytic proteinaseFEBS Letters, 1988